Nov. 7, 2019 — Baseline Ophthalmic Systems, LLC is excited to announce a new customer-focused distributor relationship with Triad Life Sciences, Inc! Based in Memphis, TN, Triad Life Sciences is a science-driven, patient-focused biotech company dedicated to the innovation of tissue-based solutions for the treatment of acute or chronic wounds, soft tissue injuries, and other regenerative applications.
Triad’s Clarity® Ocular Graft is a sterile allograft indicated for ocular surface diseases and injuries, specifically used by eye physicians for the treatment of conditions of the cornea. Clarity® allografts are comprised of placental extracellular matrices (ECM) that have been donated by consenting mothers during full-term, healthy cesarean section deliveries. Utilizing the ECM’s native immune-privileged, bioactive properties, the Clarity® Ocular Graft encourages healing by providing a biological bandage for the injury while minimizing the risk of an inflammatory response.
“We are pleased and excited about helping advance ocular treatment by adding Clarity® Ocular Grafts to our portfolio of eye care solutions. We strategically selected Triad Life Sciences based on its superior quality, value, and their focus on customer service. We look forward to helping Ophthalmologists, Optometrists and their Patients with Triad’s innovative products and services,” said Heath Queen, CEO & President of Baseline Ophthalmic Systems.
Baseline Ophthalmic Systems, LLC is based in Sarasota, FL and leads the eyecare community with expert guidance and affordable technology by offering a portfolio of technology and solutions for the advancement of eyecare to Ophthalmologists, Optometrists, and their Patients. Baseline Ophthalmic Systems is dedicated to complete customer satisfaction by delivering innovative products, superior service, and patient outcome focused value.
Related Links: www.baselineophthalmic.com / www.triadls.com
Contact: Greg C. Moser – V.P. of Business Development, Baseline Ophthalmic Systems. (513) 608-6688